Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00427765 · FLOW

Participant flow

Busulfan Plus Melphalan Conditioning Regimen for Lymphoid Malignancies or Multiple Myeloma · Source last updated 2012-01-19

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups
  1. description
    Busulfan 32 mg/m\^2 intravenous (IV) for 1 Day then 130 mg/m\^2 IV for 4 Days; and Melphalan 70 mg/m\^2 IV for 2 Days
    id
    FG000
    title
    Busulfan + Melphalan
periods
  1. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        164
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        164
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        0
      type
      NOT COMPLETED
    title
    Overall Study
pre Assignment Details
Among the participants enrolled, two were excluded from the trial before starting any treatment. There are two participants who were enrolled on the study twice (having to temporarily leave then re-enter the study).
recruitment Details
Recruitment Period: 2/4/2005 through 10/29/2010. All participant recruitment attempted at UT MD Anderson Cancer Center.
Complete source fields
groups
  1. description
    Busulfan 32 mg/m\^2 intravenous (IV) for 1 Day then 130 mg/m\^2 IV for 4 Days; and Melphalan 70 mg/m\^2 IV for 2 Days
    id
    FG000
    title
    Busulfan + Melphalan
periods
  1. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        164
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        164
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        0
      type
      NOT COMPLETED
    title
    Overall Study
pre Assignment Details
Among the participants enrolled, two were excluded from the trial before starting any treatment. There are two participants who were enrolled on the study twice (having to temporarily leave then re-enter the study).
recruitment Details
Recruitment Period: 2/4/2005 through 10/29/2010. All participant recruitment attempted at UT MD Anderson Cancer Center.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice